JP2023513735A5 - - Google Patents
Info
- Publication number
- JP2023513735A5 JP2023513735A5 JP2022548856A JP2022548856A JP2023513735A5 JP 2023513735 A5 JP2023513735 A5 JP 2023513735A5 JP 2022548856 A JP2022548856 A JP 2022548856A JP 2022548856 A JP2022548856 A JP 2022548856A JP 2023513735 A5 JP2023513735 A5 JP 2023513735A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- ptx3
- pentraxin
- hyaluronan
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062975599P | 2020-02-12 | 2020-02-12 | |
| US62/975,599 | 2020-02-12 | ||
| PCT/US2021/017773 WO2021163419A1 (en) | 2020-02-12 | 2021-02-12 | Methods of killing or inhibiting the growth of cancer cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513735A JP2023513735A (ja) | 2023-04-03 |
| JP2023513735A5 true JP2023513735A5 (cg-RX-API-DMAC7.html) | 2024-02-21 |
| JP7886270B2 JP7886270B2 (ja) | 2026-07-07 |
Family
ID=77292678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548856A Active JP7886270B2 (ja) | 2020-02-12 | 2021-02-12 | がん細胞を死滅させるまたはがん細胞の成長を阻害する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230083005A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4103592A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7886270B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220143689A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115397841A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021219772A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3170323A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021163419A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
| WO2023211823A1 (en) | 2022-04-25 | 2023-11-02 | Biotissue Holdings Inc. | Compositions and methods relating to pooled fetal support tissue |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2010115A1 (de) | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrogranulaten |
| SE8200751L (sv) | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
| US5037677A (en) | 1984-08-23 | 1991-08-06 | Gregory Halpern | Method of interlaminar grafting of coatings |
| US5356433A (en) | 1991-08-13 | 1994-10-18 | Cordis Corporation | Biocompatible metal surfaces |
| US5336518A (en) | 1992-12-11 | 1994-08-09 | Cordis Corporation | Treatment of metallic surfaces using radiofrequency plasma deposition and chemical attachment of bioactive agents |
| IT1298487B1 (it) | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| US7932365B2 (en) | 2003-11-08 | 2011-04-26 | Pro Thera Biologics, Llc | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| JP5505760B2 (ja) | 2005-09-27 | 2014-05-28 | ティッシュテク・インコーポレーテッド | 羊膜調製物及び精製組成物及びその使用方法 |
| WO2009111159A2 (en) | 2008-03-03 | 2009-09-11 | New York University | Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same |
| ES2846789T3 (es) | 2012-07-11 | 2021-07-29 | Tissuetech Inc | Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos |
| US10342831B2 (en) * | 2015-05-20 | 2019-07-09 | Tissuetech, Inc. | Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
| CN113260370A (zh) * | 2018-11-07 | 2021-08-13 | 组织技术公司 | 细胞重编程的方法 |
-
2021
- 2021-02-12 KR KR1020227031259A patent/KR20220143689A/ko active Pending
- 2021-02-12 EP EP21753538.4A patent/EP4103592A4/en active Pending
- 2021-02-12 WO PCT/US2021/017773 patent/WO2021163419A1/en not_active Ceased
- 2021-02-12 CA CA3170323A patent/CA3170323A1/en active Pending
- 2021-02-12 JP JP2022548856A patent/JP7886270B2/ja active Active
- 2021-02-12 US US17/798,421 patent/US20230083005A1/en active Pending
- 2021-02-12 AU AU2021219772A patent/AU2021219772A1/en active Pending
- 2021-02-12 CN CN202180028053.2A patent/CN115397841A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go | |
| Zhang et al. | Advancements of radiotherapy for recurrent head and neck cancer in modern era | |
| Grodsky et al. | Radiation proctopathy | |
| US20220280233A1 (en) | Devices, methods, and compositions for thermal acceleration and drug delivery | |
| Araujo et al. | Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options | |
| Martin II et al. | Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma | |
| Rogers et al. | Radiotherapy for melanoma: More than DNA damage | |
| JP2022500435A5 (cg-RX-API-DMAC7.html) | ||
| Teh et al. | Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data | |
| CN109069624A (zh) | 癌症的免疫治疗 | |
| Zhou et al. | A comprehensive review of BET-targeting PROTACs for cancer therapy | |
| CN104800858B (zh) | Hsp90抑制肽偶联物及其在肿瘤治疗中的应用 | |
| EP2780024B1 (en) | Tumor vaccination | |
| Zhao et al. | Synergistically Augmenting Cancer Immunotherapy by Physical Manipulation of Pyroptosis Induction: C. Zhao et al. | |
| Zhou et al. | New advances in treatment of skin malignant tumors with nanosecond pulsed electric field: A literature review | |
| Tian et al. | Visualized photodynamic nanomaterials activating tumor-associated immune landscape as a next-generation anticancer strategy | |
| Metcalfe et al. | The safety and efficacy of radiofrequency and electrolytic ablation created adjacent to large hepatic veins in a porcine model | |
| WO2009067520A3 (en) | Peptides specific for hepatocellular carcinoma cells and applications thereof | |
| Crijnen et al. | Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer | |
| Xu et al. | Comprehensive treatment of intermediate and advanced primary hepatocellular carcinoma based on transcatheter arterial chemoembolization | |
| CN107137407B (zh) | 一种vegfr抑制剂在制备治疗胰腺癌的药物中的用途 | |
| Lauffer et al. | Pancreatic cancer: feasibility and outcome after radiochemotherapy with high dose external radiotherapy for non-resected and R1 resected patients | |
| Sbeit et al. | Endoscopic ultrasound role in pancreatic adenocarcinoma treatment: A review focusing on technical success, safety and efficacy | |
| RU2478407C1 (ru) | Способ комбинированного лечения местно-распространенного рака желудка | |
| Kanekal et al. | Retention of intratumor injections of cisplatinum in murine tumors and the impact on laser thermal therapy for cancer treatment |